Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients (Q42277452)

19 October 2017

title

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients (English)

1 reference

19 October 2017

0 references

Paul J. Tiseo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

Howard T. Thaler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

Jeanne Lapin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

Charles E. Inturrisi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

Russell K. Portenoy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

Kathleen M. Foley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7644248

9 July 2024

language of work or name

English

0 references

publication date

1 April 1995

1 reference

full work available at URL

19 October 2017

https://journals.lww.com/10.1016/0304-3959(94)00148-8

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

9 July 2024

1 reference

19 October 2017

volume

61

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

47-54

1 reference

Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics

19 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

9 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Chronic nausea and morphine-6-glucuronide

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

9 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Potential analgesic contribution from morphine-6-glucuronide in CSF

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Long lasting respiratory depression induced by morphine-6-glucuronide?

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Oral morphine in cancer pain: influences on morphine and metabolite concentration

9 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Analgesic activity of morphine-6-glucuronide

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Morphine-6-glucuronide, a potent mu agonist.

9 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

9 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

9 July 2024

Metabolism of narcotics.

17

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Kinetics of morphine in patients with renal failure

9 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

Influence of renal function on the elimination of morphine and morphine glucuronides

9 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0304-3959(94)00148-8

9 July 2024

Identifiers

1 reference

19 October 2017

1 reference